In this Section |
270162 Identifying the barriers and facilitators to cervical cancer prevention and control in Malawi: A qualitative approachWednesday, October 31, 2012
In Malawi at least 31 out of every 100,000 women develop cervical cancer and approximately 80% of them will die from this malignancy. Malawian women have limited access to resources for prevention of cervical cancer; therefore, HPV vaccination may provide a vital strategy for primary prevention for many Malawian women. Important questions and concerns regarding cervical cancer and vaccination acceptance among individuals and their community must be considered prior to vaccine initiation.
The World Health Organization's guidelines for knowledge, attitudes, and practice surveys were used to guide in-depth, semi-structured interviews with 30 Malawian women (Mean age=32 years). One-hour interviews were conducted in Chichewa and translated into English. Women's knowledge and beliefs about cervical cancer and prevention, as well as health behaviors that women engage in were explored. Phenomenology was used to elucidate potential barriers/facilitators to widespread implementation and acceptance of HPV vaccination, as well as to uncover vital information regarding current cervical cancer prevention techniques in Malawi. Low knowledge about cervical cancer and perceived risk, distance to hospitals and lack of medical resources were identified as barriers to cervical cancer prevention. Facilitators included trust in medical professionals, perception that cervical cancer was serious, and positive experiences with vaccines. Cervical cancer prevention measures in Malawi may improve by educating women about the etiology of cervical cancer, the importance of early detection, and risk. All of the women reported that they wanted their children to get the HPV vaccine and supported the development of an HPV vaccination program in Malawi.
Learning Areas:
Social and behavioral sciencesLearning Objectives: Keywords: Cancer Prevention, Cervical Cancer
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have been the principal or co-principal investigator on multiple research projects involving HPV vaccine acceptance both within the United States and in Malawi. I have managed additional health related research projects, have secured grant funding and have published peer-reviewed scholarly articles. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 5017.0: Poster Session: Innovations in International Health 2
|